ArticleJournal of cheminformatics2025
VNFlow: integration of variational autoencoders and normalizing flows for novel molecular design.
Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Generative Artificial Intelligence is transforming the molecular discovery by enabling exploration of the vast, largely unexplored chemical space. However, current methods, including normalizing flows, struggle to balance the optimization of complex objectives and sampling speed, particularly when generating specific compound classes and more intricate scaffolds, such as aromatic rings. This work developed a generative model that efficiently samples novel molecules while optimizing their drug-likeness, ease of synthesis or chemical reactivity. To achieve this, we employed normalizing flows combined with variational autoencoders to generate samples which were evaluated for the Quantitative Estimate of Drug-likeness, the Synthetic Accessibility scores and, in case of organofluorine-phosphates, electronic density on the central phosphorus atom, approximated by Hirschfeld charges calculated with density functional theory. Our framework efficiently generated a diverse range of organofluorine-phosphates, demonstrating that combining normalizing flows directly with SELFIES or group-SELFIES can address key limitations in inverse molecular design, particularly when variational autoencoders cannot be applied due to a lack of available training data. Normalizing flows capture the chemical structures in a holistic way which paves the way towards targeted therapies that enable the optimization of complex molecular objectives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.